Certara Inc. (CERT) CEO William Feehery on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/21
Certara to Participate in Piper Sandler 33rd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/03/21
Certara Appoints Patrick F. Smith to President of Integrated Drug DevelopmentGlobeNewsWire • 10/12/21
Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission ProcessGlobeNewsWire • 09/30/21
Certara: Global Biosimulation Firm Positions Itself For Stability Into The Long TermSeeking Alpha • 09/29/21
Certara Announces New Clinical Science Group and Adds Senior Scientific ExpertsGlobeNewsWire • 09/22/21
Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using BiosimulationGlobeNewsWire • 09/20/21
Certara Announces Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 09/13/21
Certara Inc's (CERT) CEO William Feehery on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/07/21
Certara To Buy Compliance Software Provider For $310; Q2 Earnings Beat Expectations, Raises FY21 GuidanceBenzinga • 08/06/21
Certara to Acquire Pinnacle 21, a Leader in Data Standardization Software for Pharmaceutical Clinical DataGlobeNewsWire • 08/05/21
Certara's Vaccine Simulator™ Accurately Predicted Optimal Timing Between Doses for COVID-19GlobeNewsWire • 07/23/21
Certara Appoints Nancy Killefer and Cynthia Collins as New Independent Board MembersGlobeNewsWire • 07/15/21